Stockholders' Deficit (Details) - USD ($) $ / shares in Units, $ in Thousands							2 Months Ended	12 Months Ended
	Oct. 07, 2025	Jan. 18, 2024	Mar. 22, 2023	Mar. 19, 2023	Feb. 21, 2023	Dec. 02, 2021	Mar. 10, 2026	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 07, 2023	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Payments of stock issuance costs								$ 7,500	$ 0	$ 0
Common stock, shares issued (in shares)								247,210,341	197,846,661
Common stock, par value (in dollars per share)								$ 0.001	$ 0.001
Issuance costs to additional paid in capital				$ 2,900
Warrants exercised (in shares)								7,178,729	10,272,783	5,850,747
The Warrants
Subsidiary, Sale of Stock [Line Items]
Exercise price (in dollars per share)				$ 1.55
Pre Funded Warrant
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding (in shares)								0	0
Adjustment to additional-paid-in-capital for warrants issued				$ 22,800
Warrants exercised (in shares)										20,965,747
Wainwright
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding (in shares)						36,964,286
Exercise price (in dollars per share)						$ 9.00
Adjustment to additional-paid-in-capital for warrants issued						$ 61,900
Warrants expired (in shares)											27,940,074
Warrant Amendment Agreements And Securities Purchase Agreement
Subsidiary, Sale of Stock [Line Items]
Warrants outstanding (in shares)								18,892,700	26,071,429
Exercise price (in dollars per share)								$ 1.55	$ 1.55
Warrant Amendment Agreements
Subsidiary, Sale of Stock [Line Items]
Proceeds from stock offering, net			$ 55,500	1,200
Estimated offering expenses				$ 4,200
Exercise price (in dollars per share)			$ 1.55									$ 9.00
Warrants exercisable into stock (in shares)				9,024,212
Warrant expiration term			3 years 6 months
Additional consideration per amended warrant (in dollars per share)			$ 0.125
Proceeds from issuance of common stock from ATM Program, net of issuance costs				$ 51,300
Placement fees			$ 100
Proceeds from credit agreement, net of issuance costs			$ 1,100
Securities Purchase Agreement
Subsidiary, Sale of Stock [Line Items]
Common stock, shares issued (in shares)				12,205,000
Common stock, par value (in dollars per share)				$ 0.001
Common stock purchasable under prefunded warrants (in shares)				20,965,747
Common stock purchasable under warrants (in shares)				33,170,747
Securities Purchase Agreement | Common Stock And Accompanying Warrant
Subsidiary, Sale of Stock [Line Items]
Purchase price (in dollars per share)				$ 1.675
Securities Purchase Agreement | Pre Funded Warrant And Accompanying Warrant
Subsidiary, Sale of Stock [Line Items]
Purchase price (in dollars per share)				$ 1.674
October 2025 Offering
Subsidiary, Sale of Stock [Line Items]
Issued stock (in shares)	31,065,000
Price per share (in dollars per share)	$ 2.50
Proceeds from stock offering, net	$ 72,600
Estimated offering expenses	$ 5,100
Over Allotment Option
Subsidiary, Sale of Stock [Line Items]
Issued stock (in shares)		8,505,000
Option to purchase additional shares (in shares)	1,065,000
Option period		30 days
Commitment Offering
Subsidiary, Sale of Stock [Line Items]
Issued stock (in shares)		56,700,000
Price per share (in dollars per share)		$ 1.50
Proceeds from stock offering, net		$ 90,700
Estimated offering expenses		$ 7,100
At The Market Program
Subsidiary, Sale of Stock [Line Items]
Issued stock (in shares)								7,661,505	378,902	3,312,908
Proceeds from stock offering, net								$ 15,400	$ 500	$ 4,400
Authorized amount					$ 70,000
Payments of stock issuance costs								$ 400	$ 200	$ 400
Subsequent Event
Subsidiary, Sale of Stock [Line Items]
Warrants exercised (in shares)							11,250,000
Net proceeds, after issuance fees							$ 16,200